177 related articles for article (PubMed ID: 7703255)
21. Methene bridge carbon atom elimination in oxidative heme degradation catalyzed by heme oxygenase and NADPH-cytochrome P-450 reductase.
Docherty JC; Firneisz GD; Schacter BA
Arch Biochem Biophys; 1984 Dec; 235(2):657-64. PubMed ID: 6440489
[TBL] [Abstract][Full Text] [Related]
22. Replacement of the proximal histidine iron ligand by a cysteine or tyrosine converts heme oxygenase to an oxidase.
Liu Y; Moënne-Loccoz P; Hildebrand DP; Wilks A; Loehr TM; Mauk AG; Ortiz de Montellano PR
Biochemistry; 1999 Mar; 38(12):3733-43. PubMed ID: 10090762
[TBL] [Abstract][Full Text] [Related]
23. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase.
Yamazaki H; Shimada T; Martin MV; Guengerich FP
J Biol Chem; 2001 Aug; 276(33):30885-91. PubMed ID: 11413149
[TBL] [Abstract][Full Text] [Related]
25. Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation.
Yoshinaga T; Sassa S; Kappas A
J Biol Chem; 1982 Jul; 257(13):7778-85. PubMed ID: 6806282
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.
Sugishima M; Sato H; Higashimoto Y; Harada J; Wada K; Fukuyama K; Noguchi M
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2524-9. PubMed ID: 24550278
[TBL] [Abstract][Full Text] [Related]
27. Construction of plasmids and expression in Escherichia coli of enzymatically active fusion proteins containing the heme-domain of a P450 linked to NADPH-P450 reductase.
Fisher CW; Shet MS; Estabrook RW
Methods Enzymol; 1996; 272():15-25. PubMed ID: 8791758
[No Abstract] [Full Text] [Related]
28. Functional characterization of a soluble NADPH-cytochrome P450 reductase from Fusarium graminearum.
Etzerodt T; Wetterhorn K; Dionisio G; Rayment I
Protein Expr Purif; 2017 Oct; 138():69-75. PubMed ID: 28690182
[TBL] [Abstract][Full Text] [Related]
29. Demonstration that histidine 25, but not 132, is the axial heme ligand in rat heme oxygenase-1.
Ito-Maki M; Ishikawa K; Matera KM; Sato M; Ikeda-Saito M; Yoshida T
Arch Biochem Biophys; 1995 Feb; 317(1):253-8. PubMed ID: 7872792
[TBL] [Abstract][Full Text] [Related]
30. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
31. Candida albicans NADPH-P450 reductase: expression, purification, and characterization of recombinant protein.
Park HG; Lim YR; Eun CY; Han S; Han JS; Cho KS; Chun YJ; Kim D
Biochem Biophys Res Commun; 2010 May; 396(2):534-8. PubMed ID: 20435019
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
33. Functional expression of mosquito NADPH-cytochrome P450 reductase in Escherichia coli.
Kaewpa D; Boonsuepsakul S; Rongnoparut P
J Econ Entomol; 2007 Jun; 100(3):946-53. PubMed ID: 17598560
[TBL] [Abstract][Full Text] [Related]
34. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
Davis CA; Dhawan IK; Johnson MK; Barber MJ
Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
[TBL] [Abstract][Full Text] [Related]
35. Detection of heme oxygenase 1 and 2 proteins and bilirubin formation.
McCoubrey WK
Curr Protoc Toxicol; 2001 May; Chapter 9():Unit 9.3. PubMed ID: 23045069
[TBL] [Abstract][Full Text] [Related]
36. Production of a recombinant hybrid hemoflavoprotein: engineering a functional NADH:cytochrome c reductase.
Barber MJ; Quinn GB
Protein Expr Purif; 2001 Nov; 23(2):348-58. PubMed ID: 11676611
[TBL] [Abstract][Full Text] [Related]
37. Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.
Deeni YY; Paine MJ; Ayrton AD; Clarke SE; Chenery R; Wolf CR
Arch Biochem Biophys; 2001 Dec; 396(1):16-24. PubMed ID: 11716457
[TBL] [Abstract][Full Text] [Related]
38. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
39. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
40. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
